Adequan® Continues as Key AQHA Sponsor

Adequan® Continues as Key AQHA Sponsor

Adequan® remains a sponsor of numerous AQHA events, extending support to horses and riders across various levels.

text size

The American Quarter Horse Association is pleased to announce another year of partnership with American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). As AQHA’s official animal health care manufacturer and official equine joint therapy product, Adequan® is proud to join AQHA in supporting horses and riders at every level. Additionally, Adequan® remains the title sponsor of the AQHA Adequan® Select World Championship Show and Adequan® Level 2 Classes, as well as a sponsor of the AQHA World Championship Show, the AQHA East and West Level 1 Championships, AQHYA World Championship Show and the AQHA Versatility Ranch Horse Championship Show.

“AQHA members want the best for their horses, whether they are competing in the performance arena, working on a ranch or riding on the trail,” said Karl Stressman, AQHA chief executive officer. “Adequan® is dedicated to the health and well-being of our beloved American Quarter Horses.”

American Regent Animal Health and Adequan® are passionate about the American Quarter Horse. That’s why they continue sponsoring AQHA with a partnership now in its 14th year.

“Adequan® takes pride in our legacy of supporting horses and riders for over 30 years, so a partnership that allows us to continue this legacy just makes sense,” said Marjorie Lathrop, marketing director at American Regent Animal Health. “We are excited to join forces with AQHA for another year as we help keep horses and their riders moving.”

For more information (including indications and important safety information) about Adequan® and other AQHA corporate partners, visit

About American Regent Animal Health

American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for over three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit or call 800-458-0163.

AQHA news and information is a service of the American Quarter Horse Association. For more information visit or tune into our Podcast, “Let's Talk AQHA.”